Quel est le prix pour Prince Pharmaceutical Co., Ltd. (6935)

Le prix pour Prince Pharmaceutical Co., Ltd. (6935) est $0.89991249

Quelle est la capitalisation boursière pour Prince Pharmaceutical Co., Ltd. (6935)

La capitalisation boursière pour Prince Pharmaceutical Co., Ltd. (6935) est $33.67M

Prince Pharmaceutical Co., Ltd. (6935) Prix et Capitalisation Boursière

Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.

Prix pour 6935	L’actif B	La capitalisation boursière de B	Résultats
$141,687 $33.67M	NVDA	$5.301T	+15,744,469.81%
$123,859 $33.67M	AAPL	$4.634T	+13,763,355.31%
$110,738 $33.67M	GOOG	$4.143T	+12,305,328.18%
$95,940.65 $33.67M	MSFT	$3.589T	+10,661,008.74%
$76,363.62 $33.67M	AMZN	$2.857T	+8,485,572.04%

Prix pour 6935

L’actif B

La capitalisation boursière de B

Résultats

$141,687 $33.67M